Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Ratios

Scientific Industries (SCND) Gains from Investment Securities (2017 - 2025)

Scientific Industries (SCND) has 15 years of Gains from Investment Securities data on record, last reported at $84400.0 in Q3 2025.

  • For Q3 2025, Gains from Investment Securities rose 3.43% year-over-year to $84400.0; the TTM value through Sep 2025 reached -$63000.0, down 118.23%, while the annual FY2022 figure was $1.2 million, 1.87% down from the prior year.
  • Gains from Investment Securities reached $84400.0 in Q3 2025 per SCND's latest filing, down from $85600.0 in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $1.1 million in Q4 2022 and bottomed at -$345900.0 in Q2 2021.
  • Average Gains from Investment Securities over 5 years is $57165.3, with a median of $36700.0 recorded in 2022.
  • Peak YoY movement for Gains from Investment Securities: skyrocketed 558005.0% in 2022, then tumbled 495.43% in 2023.
  • A 5-year view of Gains from Investment Securities shows it stood at -$200.0 in 2021, then surged by 558005.0% to $1.1 million in 2022, then tumbled by 91.35% to $96500.0 in 2023, then crashed by 358.03% to -$249000.0 in 2024, then soared by 133.9% to $84400.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Gains from Investment Securities were $84400.0 in Q3 2025, $85600.0 in Q2 2025, and $16000.0 in Q1 2025.